Cordyceps Sunshine has extended its market footprint in the world’s largest traditional Chinese herbal medicine market with the introduction of their Cinnamomum product line. 

THE BAJA POST
NEWSROOM
SOURCE: PR NEWSMEDIA

Cordyceps Sunshine Group【C.S】Group, having recently achieved a successful U.S. IPO, hosted the ‘2024 China International Biomedical Innovation Development Conference and Chinese Rare Medicinal Herbs Cinnamomum Industry Transformation and Upgrade Conference’ at the Academic Lecture Hall of the Oriental Hospital of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, in Beijing on January 20, 2024.

The event saw participation from esteemed experts, and scholars spanning across Mainland China, Hong Kong, Macau, Taiwan, and national-level biomedical groups, traditional Chinese medicine technology, agricultural science, medical colleges, clinical medical research foundations, healthcare management institutions, research institutions, investment firms, totaling nearly 200 attendees.

National Recognition for Ganoderma Industry for the First Time

General Su Yuanfu, former Deputy Dean of the People’s Liberation Army General Hospital, served as the Chairman of the Conference. The event was co-hosted by Professor Zhang Taojing, Chairman of the Academic Committee of the Conference and Vice Dean of the Oriental Hospital of Traditional Chinese Medicine at Beijing University of Chinese Medicine, and Researcher Zhang Haifeng, Director of the Sino-Foreign Traditional Medicine Exchange and Cooperation Center.

The theme of the forum was «Biotechnology: Creating Value, Safeguarding Endangered Medicinal Resources, and Enhancing the Industry Chain.»

The discussions centered around the expansion and application of Taiwan’s unique medicinal fungus – Cinnamomum, collectively exploring the Cinnamomum industry in the Greater China region.